Literature DB >> 21668037

Efficacy and safety of long-acting reversible contraception.

Amy Stoddard1, Colleen McNicholas, Jeffrey F Peipert.   

Abstract

Long-acting reversible contraception (LARC) includes intrauterine devices (IUDs) and the subdermal implant. These methods are the most effective reversible methods of contraception, and have the additional advantages of being long-lasting, convenient, well liked by users and cost effective. Compared with other user-dependent methods that increase the risk of noncompliance-related method failure, LARC methods can bring 'typical use' failure rates more in line with 'perfect use' failure rates. LARC methods are 'forgettable'; they are not dependent on compliance with a pill-taking regimen, remembering to change a patch or ring, or coming back to the clinician for an injection. LARC method failure rates rival that of tubal sterilization at <1% for IUDs and the subdermal implant. For these reasons, we believe that IUDs and implants should be offered as first-line contraception for most women. This article provides a review of the LARC methods that are currently available in the US, including their effectiveness, advantages, disadvantages and contraindications. Additionally, we dispel myths and misconceptions regarding IUDs, and address the barriers to LARC use.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21668037      PMCID: PMC3662967          DOI: 10.2165/11591290-000000000-00000

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  49 in total

1.  Adolescents and IUCDs--Not a contraindication.

Authors:  Jenna McNaught
Journal:  J Pediatr Adolesc Gynecol       Date:  2006-08       Impact factor: 1.814

2.  Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia.

Authors:  Mira Harrison-Woolrych; Richard Hill
Journal:  Contraception       Date:  2005-04       Impact factor: 3.375

3.  The management of intrauterine devices following uterine perforation.

Authors:  A Adoni; A Ben Chetrit
Journal:  Contraception       Date:  1991-01       Impact factor: 3.375

4.  Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia.

Authors:  J K Andersson; G Rybo
Journal:  Br J Obstet Gynaecol       Date:  1990-08

5.  Removal of an intrauterine device and the treatment of acute pelvic inflammatory disease.

Authors:  K Teisala
Journal:  Ann Med       Date:  1989-02       Impact factor: 4.709

6.  Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.

Authors:  I Sivin; J Stern; S Diaz; M Pavéz; F Alvarez; V Brache; D R Mishell; M Lacarra; T McCarthy; P Holma
Journal:  Am J Obstet Gynecol       Date:  1992-04       Impact factor: 8.661

7.  Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.

Authors:  I Sivin; J Stern; E Coutinho; C E Mattos; S el Mahgoub; S Diaz; M Pavez; F Alvarez; V Brache; F Thevenin
Journal:  Contraception       Date:  1991-11       Impact factor: 3.375

8.  The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women.

Authors:  Kanok Jindabanjerd; Surasak Taneepanichskul
Journal:  J Med Assoc Thai       Date:  2006-10

9.  The effects of implanon in the symptomatic treatment of endometriosis.

Authors:  Jirawat Ponpuckdee; Surasak Taneepanichskul
Journal:  J Med Assoc Thai       Date:  2005-10

Review 10.  The effects of Implanon on menstrual bleeding patterns.

Authors:  Diana Mansour; Tjeerd Korver; Maya Marintcheva-Petrova; Ian S Fraser
Journal:  Eur J Contracept Reprod Health Care       Date:  2008-06       Impact factor: 1.848

View more
  38 in total

1.  Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.

Authors:  Alexis K Matusiewicz; Heidi S Melbostad; Sarah H Heil
Journal:  Contraception       Date:  2017-08-02       Impact factor: 3.375

2.  Controlled-release systemic delivery - a new concept in cancer chemoprevention.

Authors:  Ramesh C Gupta; Shyam S Bansal; Farrukh Aqil; Jeyaprakash Jeyabalan; Pengxiao Cao; Hina Kausar; Gilandra K Russell; Radha Munagala; Srivani Ravoori; Manicka V Vadhanam
Journal:  Carcinogenesis       Date:  2012-06-13       Impact factor: 4.944

3.  The Use of ACOG Guidelines: Perceived Contraindications to IUD and Implant Use Among Family Planning Providers.

Authors:  Ash E Philliber; Heather Hirsch; Claire D Brindis; Rita Turner; Susan Philliber
Journal:  Matern Child Health J       Date:  2017-09

4.  Adverse Birth Outcomes in Colorado: Assessing the Impact of a Statewide Initiative to Prevent Unintended Pregnancy.

Authors:  Lisa M Goldthwaite; Lindsey Duca; Randi K Johnson; Danielle Ostendorf; Jeanelle Sheeder
Journal:  Am J Public Health       Date:  2015-07-16       Impact factor: 9.308

Review 5.  Bioavailability of phytochemicals and its enhancement by drug delivery systems.

Authors:  Farrukh Aqil; Radha Munagala; Jeyaprakash Jeyabalan; Manicka V Vadhanam
Journal:  Cancer Lett       Date:  2013-02-19       Impact factor: 8.679

6.  Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont.

Authors:  Catalina N Rey; Gary J Badger; Heidi S Melbostad; Deborah Wachtel; Stacey C Sigmon; Lauren K MacAfee; Anne K Dougherty; Sarah H Heil
Journal:  Contraception       Date:  2020-02-01       Impact factor: 3.375

7.  Enhanced activity of punicalagin delivered via polymeric implants against benzo[a]pyrene-induced DNA adducts.

Authors:  Farrukh Aqil; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Mutat Res       Date:  2012-01-05       Impact factor: 2.433

8.  Consenting to invasive contraceptives: an ethical analysis of adolescent decision-making authority for long-acting reversible contraception.

Authors:  Rosemary Talbot Behmer Hansen; Kavita Shah Arora
Journal:  J Med Ethics       Date:  2018-06-14       Impact factor: 2.903

9.  Evaluating the Whoops Proof S.C. Campaign: A Pair-Matched Group Pretest-Posttest Quasi-experimental Study.

Authors:  Beth Sundstrom; Deborah Billings; Ellie Smith; Merissa Ferrara; Bill Albert; Katherine Suellentrop
Journal:  Matern Child Health J       Date:  2019-08

10.  Maternal depression and rapid subsequent pregnancy among first time mothers.

Authors:  Loral Patchen; Robin Gaines Lanzi
Journal:  MCN Am J Matern Child Nurs       Date:  2013 Jul-Aug       Impact factor: 1.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.